Stefan J Erkeland

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Listeria Monocytogenes

Long Noncoding Rna

Acute Lymphoblastic Leukemia

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Stefan J Erkeland
Computational analysis of a microRNA signature for poor prognosis suggests a microRNA-controlled stemness pathway in paediatric acute leukaemia. British journal of haematology (2023)
Christiaan J Stavast, Iris van Zuijen, Stefan J Erkeland
MicroRNA-139 , an Emerging Gate-Keeper in Various Types of Cancer. Cells 11 (5) (2022)
Martijn W C Verbeek, Stefan J Erkeland, Vincent H J van der Velden
Dysregulation of Small Nucleolar RNAs in B-Cell Malignancies. Biomedicines 10 (6) (2022)
Jennifer L Hope, Manzhi Zhao, Christopher J Stairiker, Caoimhe H Kiernan, Alison J Carey, Yvonne M Mueller, Marjan van Meurs, Inge Brouwers-Haspels, Dennis C Otero, Eun-Ah Bae, Hannah A Faso, Alex Maas, Hans de Looper, Paolo M Fortina, Isidore Rigoutsos, Linda M Bradley, Stefan J Erkeland, Peter D Katsikis
MicroRNA-139 Expression Is Dispensable for the Generation of Influenza-Specific CD8 + T Cell Responses. Journal of immunology (Baltimore, Md. : 1950) 208 (3) (2022)
Jorn L J C Assmann, Leticia G Leon, Christiaan J Stavast, Sanne E van den Bogaerdt, Joyce Schilperoord-Vermeulen, Yorick Sandberg, Mar Bellido, Stefan J Erkeland, Thomas P Loughran, Thomas P Loughran, Anton W Langerak
miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia. Leukemia (2021)
Christiaan J Stavast, Iris van Zuijen, Elena Karkoulia, Arman Özçelik, Antoinette van Hoven-Beijen, Leticia G Leon, Jane S A Voerman, George M C Janssen, Peter A van Veelen, Monika Burocziova, Rutger W W Brouwer, Wilfred F J Van IJcken, Alex Maas, Eric M Bindels, Vincent H J van der Velden, Christopher Schliehe, Peter D Katsikis, Meritxell Alberich-Jorda, Stefan J Erkeland
The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesis. Leukemia (2021)
Manzhi Zhao, Caoimhe H Kiernan, Christopher J Stairiker, Jennifer L Hope, Leticia G Leon, Marjan van Meurs, Inge Brouwers-Haspels, Ruben G Boers, Joachim Boers, Joost Gribnau, Wilfred F J Van IJcken, Eric M Bindels, Remco M Hoogenboezem, Stefan J Erkeland, Yvonne M Mueller, Peter D Katsikis
Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation. PLoS pathogens 16 (6) (2020)